LivaNova PLC (FRA:LIA)

Market Cap	3.02B +20.1%
Revenue (ttm)	1.15B +8.6%
Net Income	-185.36M
EPS	-3.40
Shares Out	n/a
PE Ratio	n/a
Forward PE	16.33
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	53.00
Previous Close	53.50
Day's Range	53.00 - 53.00
52-Week Range	29.60 - 55.50
Beta	n/a
RSI	49.50
Earnings Date	Feb 25, 2026

About LivaNova

LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connect...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2015
• Employees: 2,900
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: LIA

Financial Performance

In 2024, LivaNova's revenue was $1.25 billion, an increase of 8.66% compared to the previous year's $1.15 billion. Earnings were $63.23 million, an increase of 260.39%.

Financial numbers in USD